NicOx S.A. | Ownership

Companies that own NicOx S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Apo Asset Management GmbH
323,959
1.1%
129,816
0.12%
06/29/2018
Santander Private Banking Gestion SA SGIIC
288,202
0.97%
80,031
0.06%
03/31/2018
OFI Asset Management SA
283,380
0.96%
0
0.05%
05/31/2018
Dimensional Fund Advisors LP
195,111
0.66%
0
0%
04/30/2018
Medical Strategy GmbH
180,631
0.61%
53,000
0.88%
11/30/2017
Mackenzie Financial Corp.
86,259
0.28%
0
0%
06/30/2018
Aramea Asset Management AG
75,000
0.25%
17,500
0.17%
09/30/2017
Amilton Asset Management SA
44,737
0.15%
44,737
0.18%
06/30/2017
Sectoral Asset Management, Inc.
31,282
0.11%
8,800
0.03%
11/30/2017
Deka Investment GmbH
25,750
0.09%
-247
0%
03/29/2018

About NicOx

View Profile
Address
Drakkar 2 - Bât D
Sophia-Antipolis Provence-Alpes-Cote-dAzur 06560
France
Employees -
Website http://www.nicox.com
Updated 07/08/2019
Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health. Its products include Zerviate, and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.